News and Announcements

Faculty, trainees, students and staff gathered on September 23 for the 16th Annual Medical Education Day, a yearly celebration of teaching excellence, educational innovation and scholarship across the Feinberg community.

A new Northwestern Medicine study suggests a major psychiatric risk gene remains important well into adulthood and may influence brain communication, according to a study published in the Proceedings of the National Academy of Sciences. 

A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for the novel approach to treating neurological disorders.

The field of neurodevelopmental research has evolved over the past decade with major advances in genetics, brain imaging and laboratory models. Large genomic studies have uncovered many more genes associated with risk of developing autism, schizophrenia and related conditions, while new technologies, including brain organoids grown from patients' stem cells, are giving scientists new insight into how these disorders develop and affect brain function.  

Faculty, clinicians, investigators and community members gathered on May 19 for Alzheimer Day, an annual conference dedicated to advancing understanding of dementia and connecting cutting-edge research with patients and families.

The post Alzheimer Day Highlights Research Advances and Community Engagement  appeared first on News Center.

A new Northwestern Medicine study provides evidence that ALS unfolds through a domino‑like sequence of events that begins with an early breakdown inside motor neurons and is followed by a damaging inflammatory response.

A new computational method could dramatically accelerate efforts to map the body’s cells in space, according to a study published in Nature Genetics.

A global team of scientists has uncovered a new genetic risk factor for a rare and aggressive form of early-onset dementia, according to a study published in Nature Genetics.

The post Uncovering a Genetic Driver of Rare Early-Onset Dementia  appeared first on News Center.

A new Northwestern study in humans and mice has discovered a novel biomarker of schizophrenia that could also serve as a new drug candidate to treat the cognitive symptoms of the disorder.

Northwestern Medicine scientists have discovered an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson’s disease, according to a recent study published in The Journal of Clinical Investigation.

New research shows that the brains of “SuperAgers” continue to generate new neurons in the hippocampus at levels far higher than typical older adults, and even much younger individuals.

The post As Superagers Age, They Make at Least Twice as Many New Neurons as Their Peers appeared first on News Center.

Participants stopped meals three hours before bed, dimmed the lights and extended their overnight fast by two hours

Northwestern University scientists have pinpointed when and where toxic proteins accumulate within the brains of Alzheimer’s patients — and discovered a decades-old Food and Drug Administration (FDA)-approved drug that can stop the accumulation process before it even begins, according to a recent study published in Science Translational Medicine.

Northwestern University has launched the Simpson Querrey Brain Health Institute (SQ-Brain), made possible by nearly $25 million in philanthropic funding from university trustee Kimberly K. Querrey.

The post New Institute Envisions Future Where Our Brains Last as Long as Our Bodies appeared first on News Center.

Northwestern Medicine scientists have zeroed in on a cellular gatekeeper that may hold promise for treating abnormal protein accumulation in neurodegenerative diseases, according to a study published in Nature Communications. 

Northwestern Medicine scientists have zeroed in on a cellular gatekeeper that may hold promise for treating abnormal protein accumulation in neurodegenerative diseases, according to a study published in Nature Communications. 

Feinberg experienced a year of discovery and scientific achievement in 2025, from honors and awards to unprecedented research discoveries.

In a new study, scientists have identified a previously unknown driver of Alzheimer’s disease, and an experimental drug developed at Northwestern University has demonstrated further promise as an early intervention to treat the disease.

A Northwestern Medicine study has shed light on a critical molecular mechanism underlying amyotrophic lateral sclerosis (ALS), according to findings published in the journal Neuron. 

This year, the Breakthroughs podcast released 17 episodes on topics including improvements in mental healthcare delivery, precision medicine therapies for rare diseases, an introduction to bedside medicine and much more.

Northwestern scientists, clinicians and people living with ALS gathered to learn about the latest research and celebrate advancements in patient care during the 15th annual Les Turner Symposium on ALS held at Northwestern Memorial Hospital on November 3.

Northwestern scientists, clinicians and people living with ALS gathered to learn about the latest research and celebrate advancements in patient care during the 15th annual Les Turner Symposium on ALS held at Northwestern Memorial Hospital on November 3.

A new Northwestern study has uncovered how a key disease protein drives overactive nerve cells in neurodegenerative diseases like ALS and frontotemporal dementia.